34.83
Centene Corp stock is traded at $34.83, with a volume of 8.31M.
It is down -3.12% in the last 24 hours and down -2.19% over the past month.
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.
See More
Previous Close:
$35.95
Open:
$36.01
24h Volume:
8.31M
Relative Volume:
0.71
Market Cap:
$17.11B
Revenue:
$178.19B
Net Income/Loss:
$2.05B
P/E Ratio:
8.6113
EPS:
4.0447
Net Cash Flow:
$1.08B
1W Performance:
-3.49%
1M Performance:
-2.19%
6M Performance:
-43.79%
1Y Performance:
-41.07%
Centene Corp Stock (CNC) Company Profile
Name
Centene Corp
Sector
Industry
Phone
(314) 725-4477
Address
7700 FORSYTH BLVD., ST LOUIS
Compare CNC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
CNC
Centene Corp
|
34.83 | 17.67B | 178.19B | 2.05B | 1.08B | 4.0447 |
|
UNH
Unitedhealth Group Inc
|
311.54 | 279.99B | 435.16B | 18.37B | 17.37B | 19.16 |
|
CVS
Cvs Health Corp
|
76.04 | 97.18B | 393.94B | 428.00M | 6.29B | 0.3826 |
|
CI
Cigna Group
|
269.60 | 72.66B | 268.22B | 6.55B | 7.44B | 22.67 |
|
ELV
Elevance Health Inc
|
313.99 | 70.31B | 194.82B | 5.53B | 3.77B | 24.45 |
|
HUM
Humana Inc
|
223.29 | 27.53B | 123.11B | 1.58B | 2.44B | 13.03 |
Centene Corp Stock (CNC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-14-25 | Initiated | Goldman | Sell |
| Jul-28-25 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jul-23-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-21-25 | Downgrade | TD Cowen | Buy → Hold |
| Jul-16-25 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-10-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-02-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-02-25 | Downgrade | UBS | Buy → Neutral |
| Jun-09-25 | Resumed | Morgan Stanley | Overweight |
| Jun-02-25 | Downgrade | Barclays | Overweight → Equal Weight |
| Apr-08-25 | Upgrade | Jefferies | Underperform → Hold |
| Feb-06-25 | Downgrade | Argus | Buy → Hold |
| Dec-17-24 | Resumed | JP Morgan | Overweight |
| Dec-13-24 | Upgrade | UBS | Neutral → Buy |
| Dec-10-24 | Downgrade | Jefferies | Hold → Underperform |
| Jul-24-24 | Downgrade | Jefferies | Buy → Hold |
| May-30-24 | Initiated | Robert W. Baird | Neutral |
| Mar-21-24 | Downgrade | Stephens | Overweight → Equal-Weight |
| Mar-06-24 | Initiated | Barclays | Overweight |
| Jan-02-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Sep-05-23 | Upgrade | BofA Securities | Underperform → Neutral |
| Aug-30-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-12-23 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jun-20-23 | Initiated | UBS | Neutral |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-08-23 | Downgrade | Deutsche Bank | Buy → Hold |
| Feb-23-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-13-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Sep-30-22 | Initiated | Argus | Buy |
| Aug-26-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-28-22 | Resumed | Barclays | Overweight |
| Jul-14-22 | Upgrade | Jefferies | Hold → Buy |
| Jun-21-22 | Upgrade | Credit Suisse | Neutral → Outperform |
| Jun-17-22 | Initiated | Loop Capital | Buy |
| May-27-22 | Resumed | Bernstein | Outperform |
| May-26-22 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-07-22 | Resumed | Barclays | Overweight |
| Jan-06-22 | Resumed | JP Morgan | Overweight |
| Dec-14-21 | Initiated | Goldman | Neutral |
| Dec-13-21 | Reiterated | BMO Capital Markets | Outperform |
| Dec-13-21 | Reiterated | BofA Securities | Buy |
| Dec-13-21 | Reiterated | Credit Suisse | Neutral |
| Dec-13-21 | Reiterated | Mizuho | Neutral |
| Dec-13-21 | Reiterated | Oppenheimer | Outperform |
| Dec-13-21 | Reiterated | Stephens | Overweight |
| Dec-13-21 | Reiterated | Truist | Buy |
| Dec-13-21 | Reiterated | Wells Fargo | Overweight |
| Dec-13-21 | Reiterated | Wolfe Research | Outperform |
| Nov-01-21 | Downgrade | Citigroup | Buy → Neutral |
| Sep-10-21 | Initiated | Cowen | Outperform |
| Jul-09-21 | Initiated | Seaport Global Securities | Buy |
| May-19-21 | Initiated | Wells Fargo | Overweight |
| May-11-21 | Upgrade | Stephens | Equal-Weight → Overweight |
| Mar-10-21 | Initiated | Mizuho | Neutral |
| Jan-21-21 | Resumed | Goldman | Neutral |
| Jan-15-21 | Downgrade | Jefferies | Buy → Hold |
| Sep-22-20 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jul-01-20 | Initiated | SVB Leerink | Outperform |
| Feb-05-20 | Upgrade | JP Morgan | Neutral → Overweight |
| Feb-03-20 | Resumed | Evercore ISI | Outperform |
| Jan-28-20 | Reiterated | Bernstein | Outperform |
| Jan-06-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Sep-12-19 | Initiated | Deutsche Bank | Buy |
| May-10-19 | Upgrade | Citigroup | Neutral → Buy |
| Jan-14-19 | Initiated | Stephens | Overweight |
| Oct-24-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
| Jul-18-18 | Resumed | Citigroup | Neutral |
| Dec-18-17 | Reiterated | Jefferies | Buy |
| Sep-13-17 | Reiterated | Leerink Partners | Mkt Perform |
| Jun-07-17 | Initiated | Morgan Stanley | Overweight |
| May-22-17 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-05-17 | Initiated | Deutsche Bank | Buy |
| Mar-23-17 | Downgrade | Citigroup | Buy → Neutral |
| Feb-08-17 | Reiterated | Barclays | Overweight |
| Feb-07-17 | Resumed | Cantor Fitzgerald | Overweight |
| Jan-04-17 | Initiated | Piper Jaffray | Overweight |
View All
Centene Corp Stock (CNC) Latest News
AcariaHealth Highlights National Biosimilars Education Efforts with Three Events – Company Announcement - Financial Times
Health Net and Centene Foundation Invest $1.1M to Combat Food Insecurity in California - Finviz
Centene Stock Plunges After Pulling 2025 Guidance On $1.8B ACA Blow; Retail Traders Smell ‘Tremendous Discount’ - Stocktwits
Why Centene Corporation stock is favored by pension fundsTrade Analysis Summary & Detailed Earnings Play Alerts - newser.com
Is Centene Corporation stock ideal for retirement investorsMarket Volume Report & AI Optimized Trading Strategy Guides - newser.com
Is Centene Corporation (QEN) stock in buy zone after pullback2025 Buyback Activity & Verified Short-Term Trading Plans - newser.com
Can Centene Corporation stock sustain breakout momentum2025 Major Catalysts & Reliable Entry Point Trade Alerts - newser.com
Using Ichimoku Cloud for Centene Corporation technicalsJuly 2025 Sector Moves & Risk Managed Trade Strategies - newser.com
Wellcare Enhances Offering of Affordable, Quality Medicare Advantage and Medicare Prescription Drug Plans in 2026 - Financial Times
Centene, Fidelity sued over alleged excessive 401(k) fees, misuse of forfeited assets - BenefitsPRO
Sunshine Health and Centene Foundation Make $410,000 Investment to Help Tackle Food Insecurity in Florida - Yahoo Finance
Is Centene Corporation stock protected from inflationJuly 2025 Summary & Verified Momentum Watchlists - newser.com
Why Centene Corporation stock could break out in 20252025 Fundamental Recap & Weekly Momentum Stock Picks - newser.com
Will Centene Corporation (QEN) stock sustain uptrend momentum2025 Technical Overview & Low Drawdown Trading Strategies - newser.com
Using data filters to optimize entry into Centene Corporation2025 Year in Review & Daily Profit Maximizing Tips - newser.com
What momentum indicators show for Centene Corporation stockWeekly Trading Summary & Advanced Swing Trade Entry Alerts - newser.com
Is Centene Corporation stock a buy before earnings results2025 Institutional Moves & Weekly High Potential Alerts - newser.com
Is Centene Corporation (QEN) stock worth buying before Fed action - newser.com
Buckeye Health Plan and Centene Foundation Make $200,000 Investment to Help Tackle Food Insecurity in Ohio - Yahoo Finance
Centene Corporation (CNC) Stock Price | Live Quotes & Charts | NYSE - StocksToTrade
Fidelity, Centene Face ERISA Suit for Excessive Fees, Misused Forfeitures - planadviser
Fidelity, Centene Hit With Excessive Fee, Forfeiture Misuse Complaint - plansponsor
How to build a custom watchlist for Centene CorporationTrade Analysis Summary & Free High Return Stock Watch Alerts - newser.com
Can Centene Corporation stock sustain revenue growthCEO Change & Safe Capital Preservation Plans - newser.com
How sentiment analysis helps forecast Centene CorporationInsider Buying & Stock Portfolio Risk Control - newser.com
How interest rate cuts could boost Centene Corporation stockQuarterly Trade Report & Verified Momentum Stock Alerts - newser.com
Using R and stats models for Centene Corporation forecasting2025 Analyst Calls & High Return Stock Watch Alerts - newser.com
Jim Cramer Discusses Centene (CNC) & Medicaid - Finviz
What downside risks could hit Centene Corporation (QEN) stockJuly 2025 Institutional & Expert Approved Trade Ideas - newser.com
Centene Stock Jumps 6.2% as Reddit Traders Buy the Dip Analysts Won’t Touch - AOL.com
Canada Nickel Announces the Referral of the Company's Crawford Project to the Major Projects Office by the Government of Canada - Benzinga
Centene Corp Stock (CNC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):